IRIS
TESTA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.079
AS - Asia 846
NA - Nord America 296
SA - Sud America 76
AF - Africa 9
Totale 11.306
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.935
SG - Singapore 396
US - Stati Uniti d'America 279
CN - Cina 226
VN - Vietnam 145
FR - Francia 76
BR - Brasile 45
HK - Hong Kong 21
AR - Argentina 18
DE - Germania 14
CH - Svizzera 13
MX - Messico 12
JP - Giappone 11
FI - Finlandia 10
GB - Regno Unito 8
ID - Indonesia 7
BD - Bangladesh 6
IN - India 6
EC - Ecuador 5
PK - Pakistan 5
IQ - Iraq 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
ES - Italia 3
PL - Polonia 3
PS - Palestinian Territory 3
RU - Federazione Russa 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
CL - Cile 2
CR - Costa Rica 2
IE - Irlanda 2
KR - Corea 2
NP - Nepal 2
SE - Svezia 2
AZ - Azerbaigian 1
CA - Canada 1
CG - Congo 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LT - Lituania 1
MA - Marocco 1
MM - Myanmar 1
NL - Olanda 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TR - Turchia 1
UY - Uruguay 1
Totale 11.306
Salva come PNG Salva come JPEG
Città #
Genova 6.578
Genoa 1.868
Rapallo 870
Vado Ligure 589
Singapore 179
San Jose 156
Lauterbourg 74
Ho Chi Minh City 45
Beijing 31
Hanoi 24
Hong Kong 20
Ashburn 19
New York 19
Bordighera 16
Frankfurt am Main 12
Zurich 12
Santa Clara 11
Helsinki 10
Tokyo 8
Mexico City 7
Tianjin 7
Des Moines 6
Orem 6
Rome 6
Los Angeles 5
São Paulo 5
Da Nang 4
Haiphong 4
Shanghai 4
Atlanta 3
Quito 3
Quảng Ngãi 3
Santo André 3
Vĩnh Long 3
Warsaw 3
Cape Town 2
Cardiff 2
Changsha 2
Chicago 2
City of London 2
Denver 2
Dhaka 2
Dublin 2
Flores da Cunha 2
Guangzhou 2
Gujranwala 2
Hải Dương 2
Jakarta 2
Johannesburg 2
Rio de Janeiro 2
Riyadh 2
Stockholm 2
Tashkent 2
Thái Bình 2
Việt Trì 2
Abidjan 1
Agadir 1
Alajuela 1
Algiers 1
Almendralejo 1
Alvorada 1
Amsterdam 1
Apodaca 1
Babol 1
Bagé 1
Belgrade 1
Belo Horizonte 1
Berlin 1
Bishkek 1
Boston 1
Bratislava 1
Brescia 1
Buenos Aires 1
Buffalo 1
Bình Phước 1
Bắc Giang 1
Bắc Ninh 1
Cachoeiro de Itapemirim 1
Cacoal 1
Caculé 1
Caicó 1
Camaçari 1
Campinas 1
Can Tho 1
Canoas 1
Caxias 1
Chandigarh 1
Charlotte 1
Chennai 1
Cheonan 1
Chittagong 1
Concepción del Uruguay 1
Concordia 1
Coro 1
Council Bluffs 1
Cà Mau 1
Duque de Caxias 1
Elói Mendes 1
Embu das Artes 1
Erbil 1
Totale 10.698
Salva come PNG Salva come JPEG
Nome #
5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for “best evidence”? 216
13C -Aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. 210
Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C 202
13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease 199
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up 189
A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice 186
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication 186
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis 176
Splanchnic haemodynamic effects of ketanserin in anaesthetized cirrhotic rats. 174
. Liver iron accumulation in chronic hepatittis C patients without HFE mutations: relationships with histological damage, viral load and genotype, and alpha glutathione S-transferase levels. 174
Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease 170
Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis? 162
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. 159
Effects of reduced glutathione and n-acetylcysteine on lidocaine metabolism in cimetidine treated rats 158
Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma 158
Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. 156
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens 155
Chronic hepatitis C in different populations: similar patterns of alanine aminotransferase alteration characterize similar clinical subgroups. 154
High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: Relationship with TNF-alpha levels 154
Is there a role for multiple quantitative liver function tests? 153
Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. 152
Leptin in nonalcoholic steatohepatitis: is it one of the "hits"? 152
13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-Aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis 150
MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study 149
Persistently normal aminotransferase in chronic hepatitis C virus infection: is it time to redefine parameters of "normality"? 145
Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C 144
Influence of 1-week helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test 143
Propranolol reduces the response of serum bile acids to oral chenodeoxycholic acid, possibly as a reflex reaction to reduced portal blood flow in healthy and cirrhotic subjects. 141
Liver enzyme alteration: a guide for clinicians 141
Tryglycylvasopressin-reduced portal and systemic concentrations of serum bile acids after exogenous chenodeoxycholic acid load in rats as a reflection of reduced splanchnic blood flow 139
Reply to Farinati et al.: classification of 'intermediate stage', untreated hepatocellular carcinoma patients: the neighbour's grass is not so green 137
The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis 137
HOMA, BMI, and serum leptin levels variations during antiviral treatment suggest virus-related insulin resistance in noncirrhotic, nonobese, and nondiabetic chronic hepatitis C genotype 1 patients 136
Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? 135
Can changing counseling strategy change the picture of the chronic hepatitis C patient population? 135
Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis 135
Is aspartate aminotransferase enough? 134
Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment 133
Two or more synchronous combination of noninvasive test to increase accuracy of liver fibrosis in chronic hepatitis C. 133
Effects of Interferon therapy on monoethylglycinexylidide formation in patients with chronic active hepatitis C 132
Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients 131
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study 129
The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis 129
Caffeine clearance in subjects with constitutional un conjugated hyperbilirubinemia 129
Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma 127
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? 125
Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C 123
Histological determinants of monoethylglycinexylidide formation in patients with chronic hepatitis C 123
Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients 122
Formation kinetics of the lidocaine metabolite (MEGX) in patients with chronic active hepatitis and cirrhosis 122
Surveillance for hepatocellular carcinoma in liver cirrhosis: have programmes improved because patients have? 122
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 121
Eligibility criteria for antiviral therapy in HCV-positive patients: similar things to (almost) similar people 120
Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease. 120
Progressive liver functional impairment is associated with an increase in AST/ALT ratio 118
Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection. 118
Longitudinal modifications of the MELD score have prognostic meaning in patients with liver cirrhosis 117
Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis 116
Chronic liver disease related to hepatitis C virus: age of patients seems to be a determinant of severity independently of viral genotype 114
Proposal and Validation of the AST/ALT ratio for predicting the presence of significant fibrosis in patients with chronic hepatitis C. 112
Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. 111
Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage 110
Biochemical scores could reflect histological activity in chronic hepatitis C 108
Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection 107
Effects of the association of lansoprazole, clarithromycin and metronidazole for Helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test. 103
Wilson's disease with concomitant beta thalassaemia and factor V deficiency. 103
The metabolic syndrome: all criteria are equal, but some criteria are more equal than others. 103
13C-breath tests and liver fibrosis. 99
Non-invasive assessment of liver function: trying not to miss an opportunity. 99
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 98
Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease 98
Serum prolyl-hydroxylase as an index of fibrogenic activity in chronic active hepatitis and cirrhosis 97
Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastroesophageal reflux disease. 96
Oral or intravenous lidocaine administration to perform megx test? 96
Monitoring of liver metabolic function during interferon-alpha therapy and its relationship to treatment outcome in chronic hepatitis C patients 94
Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis. 94
Probability of non-response during interferon therapy in patients with chronic hepatitis C 93
Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis. 93
Inclusion of serum bile acids in Child-Turcotte-Pugh's score can improve grading assessment of alcoholic cirrhosis. 92
Tauroursodeoxycholic acid administration as adjuvant therapy in cirrhotic patients on transplantation waiting lists. 90
Postprandial serum bile acids after ursodeoxycholic acid. A possible test of intestinal absorption? 88
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. 86
Plasma aminoacid ratios in alcoholic cirrhotics with subclinical encephalopathy: relationships with cerebral blood flow. 86
Malattie epatiche congenite 78
Serum bile acid profiles after endogenous and exogenous loads of bile acid into the enterohepatic circulation of healthy subjects and patiens with chronic liver disease. 76
Long-term follow-up of chronic hepatitis C patients after interferon alpha treatment: a clinical and functional study 72
Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. 59
Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data 56
Totale 11.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.045
article - articoli 34.238
book - libri 0
conference - conferenze 303
curatela - curatele 0
other - altro 256
patent - brevetti 0
selected - selezionate 0
volume - volumi 248
Totale 70.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 44 38 42
2021/20221.087 17 134 89 94 24 39 77 304 29 91 58 131
2022/20231.042 101 62 7 84 195 176 1 83 140 2 181 10
2023/2024408 18 68 8 57 35 48 13 29 14 5 43 70
2024/20251.349 50 112 39 76 195 150 100 245 51 52 111 168
2025/20261.928 281 30 113 181 288 262 408 105 99 161 0 0
Totale 11.317